HAVN Life Sciences Inc. (HAVLF) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Port Moody, BC, 캐나다. 현재 CEO는 Tim Moore.
HAVLF 을(를) 보유 IPO 날짜 2021-01-08, 6 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $2.57K.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
